Mortgage Firm Files for Bankruptcy Amid Housing Market Deep Freeze

image

(Bloomberg) — Starwood Capital-backed home lender Reverse Mortgage Funding LLC filed for Chapter 11 bankruptcy, the latest company to succumb amid a rapid run-up in mortgage rates.

The company, which makes reverse mortgages, listed assets and liabilities of at least $10 billion each in its bankruptcy petition. Chapter 11 bankruptcy allows companies to keep operating while they work on a plan to repay creditors.

Reverse mortgages, a type of home loan geared toward seniors, allow borrowers to convert equity in their homes into cash without needing to sell or pay more monthly bills.

The mortgage industry is contending with a massive slowdown in business as sky-high rates deter new borrowers. Many homeowners locked in low rates during the last two years, and now they’re reluctant to give them up.

In addition to being a lender and servicer of more than 84,000 reverse mortgage borrowers, Reverse Mortgage Funding has been a frequent seller of securitized bonds backed by mortgages. That business came under strain recently as well: late last month, the company shelved a $290 million bond sale amid market volatility.

Starwood, led by Barry Sternlicht, owns most of Reverse Mortgage Funding through investment vehicles, court papers show.

“While a difficult decision, filing for Chapter 11 protection is necessary and appropriate for RMIT given the adverse trends in the mortgage industry,” a representative for Starwood said in a statement. “We will continue to work closely with management, our advisors and the company’s stakeholders on the best path forward for the company and our investors, consistent with our fiduciary responsibilities.”

The main case is Reverse Mortgage Investment Trust Inc., 22-11225, US Bankruptcy Court for the District of Delaware.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More